|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6C
|
|
pubmed:dateCreated |
2008-1-24
|
|
pubmed:abstractText |
Concurrent chemoradiotherapy has become a standard therapy for locoregionally advanced inoperable nonsmall cell lung cancer (NSCLC). The purpose of this phase II trial was to evaluate the efficacy and toxicity of concurrent chemoradiotherapy following induction with non-platinum chemotherapy in patients with inoperable locally advanced NSCLC.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0250-7005
|
|
pubmed:author |
pubmed-author:AthanasiouHH,
pubmed-author:BakaSS,
pubmed-author:BakogiannisChCh,
pubmed-author:BoukovinasJJ,
pubmed-author:DimopoulosA MAM,
pubmed-author:FountzilasGG,
pubmed-author:GogasHH,
pubmed-author:KosmidisPP,
pubmed-author:MisailidouDD,
pubmed-author:PantelakosPP,
pubmed-author:PapacostasPP,
pubmed-author:PavlidisNN,
pubmed-author:SamantasEE,
pubmed-author:SkarlosDD,
pubmed-author:TsekerisPP
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4391-5
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:18214050-Adult,
pubmed-meshheading:18214050-Aged,
pubmed-meshheading:18214050-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18214050-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:18214050-Combined Modality Therapy,
pubmed-meshheading:18214050-Deoxycytidine,
pubmed-meshheading:18214050-Female,
pubmed-meshheading:18214050-Humans,
pubmed-meshheading:18214050-Kaplan-Meier Estimate,
pubmed-meshheading:18214050-Lung Neoplasms,
pubmed-meshheading:18214050-Male,
pubmed-meshheading:18214050-Middle Aged,
pubmed-meshheading:18214050-Paclitaxel,
pubmed-meshheading:18214050-Radiotherapy
|
|
pubmed:articleTitle |
Combination chemotherapy with paclitaxel and gemcitabine followed by concurrent chemoradiotherapy in non-operable localized non-small cell lung cancer. A hellenic cooperative oncology group (HeCOG) phase II study.
|
|
pubmed:affiliation |
Hygeia Hospital, Athens, Greece. parkosmi@otenet.gr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial, Phase II
|
